Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-19-000032
Filing Date
2019-05-02
Accepted
2019-05-02 07:26:07
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q q1201910-q.htm 10-Q 1098839
2 EXHIBIT 31.1 q12019exhibit311.htm EX-31.1 12539
3 EXHIBIT 31.2 q12019exhibit312.htm EX-31.2 12637
4 EXHIBIT 32.1 q12019exhibit321.htm EX-32.1 6826
5 EXHIBIT 32.2 q12019exhibit322.htm EX-32.2 6784
12 changeinsalt.jpg GRAPHIC 75193
13 respondersatweek26.jpg GRAPHIC 41138
14 updatedpipeline32919a01.jpg GRAPHIC 75566
  Complete submission text file 0001367920-19-000032.txt   5559846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20190331.xml EX-101.INS 1044162
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20190331.xsd EX-101.SCH 39030
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20190331_cal.xml EX-101.CAL 74647
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20190331_def.xml EX-101.DEF 181690
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20190331_lab.xml EX-101.LAB 573261
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20190331_pre.xml EX-101.PRE 331861
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 19789721
SIC: 2834 Pharmaceutical Preparations